Anchiano Therapeutics is defunct.

Merged with Chemomab, Mar 2021; fka BioCanCell; discontinued failed phase 2 gene therapy product to focus on small molecule pipeline Nov 2019


------------------
If you believe any of this information is incorrect, please let us know.